Senator Jon Ossoff and Vision to Learn Founder Austin Beutner Address National Vision Care Crisis Among School Children

June 14, 2024 11:00 AM

More than 3 million public school children lack the glasses they need. Vision To Learn has helped over 150,000 Georgia kids and provided more than 34,000 with glasses since 2017. Senator Ossoff delivered $400,000 in federal funding to help Vision To Learn provide more students with vision care in Georgia.NORCROSS, GA / ACCESSWIRE / June 14, 2024 / Senator Jon Ossoff and Vision To Learn Founder Austin Beutner highlighted the need to provide...

Read more

Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA

June 14, 2024 8:00 AM

Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and VELDONA low-dose interferon therapeutics, today announced critical progress in the clinical trials of its revolutionary "Ainos Flora" volatile organic compound ("VOC") POCT device that is based upon its transformative AI-powered digital nose ("AI Nose") technology. Designed to provide...

Read more

Avinger Announces Pricing of up to $24 Million Public Offering

June 14, 2024 8:00 AM

$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series WarrantsREDWOOD CITY, CA / ACCESSWIRE / June 14, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the pricing of a...

Read more

Cantargia Reports Further Progress in Ongoing Phase 1 Clinical Trial with CAN10

June 14, 2024 5:30 AM

LUND, SE / ACCESSWIRE / June 14, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; NasdaqStockholm:CANTA) today reported progress in the ongoing phase 1 clinical trial of the CAN10 antibody. Seven dose groups have now been concluded without any safety concerns. Furthermore, additional receptor occupancy studies confirm that CAN10 saturates its target molecule, IL1RAP, on immune cells from the study participants. The study follows timelines...

Read more

Protagonist Reports Updated Long Term Results from Rusfertide Phase 2 REVIVE Study at the EHA2024 Congress Showing Durable Hematocrit Control

June 14, 2024 3:00 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced details from two abstracts at the European Hematology Association 2024 Congress, including an oral presentation with long-term follow-up data from the Phase 2 REVIVE study with rusfertide, a mimetic of the natural hormone hepcidin with potential therapeutic value in the treatment of polycythemia vera (PV) and other disease indications. Copies of the presentations will be...

Read more

Digital Case Acceptance Platform Reports Record Data for Case Acceptance and Productivity After Months of Testing

June 13, 2024 2:00 PM

Today, AcceptCare reports record data from dental practices across the country using the digital case acceptance platform. Key highlights include:Up to 76% case acceptance rate using AcceptCare43% higher treatment acceptance than the average practice not using AcceptCare24% of patients accept or pay for treatment from home, within 30 days post-consult15% increase in elective treatment productionClarksburg Dental in Maryland reported substantial...

Read more

Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million

June 13, 2024 9:25 AM

CHICAGO, IL / ACCESSWIRE / June 13, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the successful closing of the acquisition of the pharmacy distribution network...

Read more

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health

June 13, 2024 9:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health ("NYSDOH") approved the Company's TR8™ PGx ("TR8") pharmacogenomic (PGx) testing service. The Company is currently in discussions to provide large-scale testing to enterprise customers, healthcare networks, and concierge physicians seeking to add PGx testing to their test...

Read more

SpendMend's Trulla Software Platform Chosen to Optimize Pharmacy Procurement at Froedtert Health

June 13, 2024 9:00 AM

GRAND RAPIDS, MI / ACCESSWIRE / June 13, 2024 / SpendMend, a leading provider of solutions to optimize the cost-cycle for the healthcare industry, is proud to announce that Froedtert Health has selected Trulla to streamline and enhance its health system pharmaceutical procurement processes.Froedtert Trulla is a cloud-based application developed by pharmacists to enable health systems to manage pharmacy ordering across multiple locations within a...

Read more

InteliChart Tops Black Book 2024 Survey for Best Client Experience in Patient Engagement Platforms, Second Consecutive Year

June 13, 2024 8:00 AM

TAMPA, FL / ACCESSWIRE / June 13, 2024 / Black Book Research has announced the leading platform vendors, as rated by customers, in the areas of patient engagement and consumer outreach solutions. These top-rated vendors offer innovative capabilities in scheduling, intake, and notifications. The comprehensive six-month user polls encompassed twenty technology competitors, all of which provide advanced tools for optimized collaboration and...

Read more

FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications

June 13, 2024 7:30 AM

TORONTO, ON / ACCESSWIRE / June 13, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces that it entered into an exclusive option agreement with the University of Southern California (USC) to evaluate dietary supplement technology for commercialization. The...

Read more

Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine

June 13, 2024 7:00 AM

CAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine, has met its primary efficacy endpoint, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax. The Company also announced that higher efficacy was observed in adults 18 years of age and older compared to Spikevax (mRNA-1273), with a consistent...

Read more

New Scientific Article Published on Positive Clinical Results with Painless ACD440 Against Neuropathic Pain

June 13, 2024 4:20 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / June 13, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that a scientific article has been published on the clinical phase Ib results that support the continued development of the lead drug candidate Painless ACD440.The...

Read more

Canadian Insulin Leading the Way With Affordable Wegovy North of the Border

June 12, 2024 1:30 PM

REGINA, SK / ACCESSWIRE / June 12,2024 / Canadian prescription referral service Canadian Insulin is amongst the first of its Canadian and international rivals to now supply the hugely popular FDA-approved weight loss medication Wegovy to thousands of Americans at a fraction of the price they'd pay at their local US pharmacies. "At Canadian Insulin, we believe Americans shouldn't have to pay nearly twice as much as their northern neighbors for...

Read more

Women in Science? At Merck, Absolutely

June 12, 2024 12:45 PM

NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Merck & Co., Inc.Strong career paths and cutting-edge science draw more women scientists - like chemists and engineers - to the company's small molecule process R&D teamWomen scientists have historically been underrepresented in the field of process research and development - the space between drug discovery and manufacturing. However, over the past seven years, the percentage of women on Merck's...

Read more

OptiMed Introduces a New Service for Treatment-Resistant Depression, Providing Mental Health Support in Munster, Indiana

June 12, 2024 12:00 PM

OptiMed provides SPRAVATO® treatment services to Northwest Indiana and Chicagoland area.MUNSTER, IN / ACCESSWIRE / June 12, 2024 / OptiMed HealthCare Partners is pleased to announce the opening of its new center in Munster, Indiana. SPRAVATO® is the first FDA-approved nasal spray for treatment-resistant depression (TRD). OptiMed is proud to lead the change in mental health care by expanding this treatment to Munster, IN. Welcoming New Patients...

Read more

My Quest Story - Mark Hamilton

June 12, 2024 11:15 AM

NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Quest Diagnostics I've spent most of my career working in an industry where lives are on the line. Prior to coming to Quest Diagnostics, I worked in transportation in the airline industry as a ramp agent. My job responsibilities included using body signals to communicate with the pilot to direct planes-we had to say a lot to each other without saying a word. I also managed loading, stowing, and...

Read more

Physiowell's Role in Advancing Public Health Through Community Involvement

June 12, 2024 10:40 AM

Promoting Wellness Through Community Events and Relevant AssessmentsDUBAI, UAE / ACCESSWIRE / June 12, 2024 / Physiowell Clinic, a Dubai-based health center, has played a vital role in promoting public health campaigns in the UAE, exhibiting an unwavering dedication towards improving community wellness. Being one of the top-ranked physiotherapy, osteopathy and chiropractic clinics in Dubai, Physiowell participates enthusiastically in multiple...

Read more

Serve You Rx Launches Biosimilar Advantage Formulary to Provide Lower Upfront Cost Options for Specialty Drugs

June 12, 2024 10:00 AM

New Formulary Strategy Advances Biosimilar Adoption and AffordabilityMILWAUKEE, WI / ACCESSWIRE / June 12, 2024 / Serve You Rx, a full-service pharmacy benefit manager (PBM) known for its unquestionable flexibility and unwavering commitment to doing what's best for its clients, today announced the launch of its new Biosimilar Advantage Formulary. This formulary strategy, designed to accelerate the adoption of biosimilars, positions selected...

Read more

SFWJ/MedCana Announces Strategic Partnership with Colombian Company to Begin Exporting CBD Buds to Switzerland

June 12, 2024 9:45 AM

SFWJ, doing business as Medcana, a holding company focused in the cannabis and agricultural technology sectors is pleased to announce a new strategic partnership with one of its subsidiaries with a prominent local Colombian company to begin the export of its first crop of CBD buds to Switzerland within the next six months. This collaboration marks a significant milestone in MedCana's expansion into the European market and its commitment to...

Read more